The possible role of glucose-6-phosphate dehydrogenase deficiency in COVID-19 global prevalence and distribution

Abstract

The new coronavirus 2019 (nCoV‑19), also known as severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), was first reported on December 2019 and began an outbreak known as a pandemic declared by the World Health Organization (WHO). Given the rapid spread of coronavirus disease 2019 (COVID‑19) worldwide, morbidity and mortality rate is increasing rapidly every day. nCoV‑19 is a novel species of positive‑sense, single‑stranded RNA of Coronaviridae family categorized as beta coronaviruses subfamily along with SARS‑CoV and Middle East respiratory syndrome coronavirus.